Work

Phase IB clinical trial of anti-CD3 followed by high-dose bolus interleukin-2 in patients with metastatic melanoma and advanced renal cell carcinoma: clinical and immunologic effects.

Year: 1993

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.1993.11.8.1496

Authors: J A Sosman, G R Weiss, K A Margolin, F R Aronson, M Sznol, M B Atkins, K O'Boyle, R I Fisher, D H Boldt, J Doroshow

Institution: Loyola University Medical Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G1105070095, CLINICAL TRIALS OF ACTIVATED HUMAN LEUKOCYTES

OpenAlex ID: W2223317700

FWCI: 1.825

Cites: 43

Cited by: 45

Related to: 10